/
INTI
$0.09+$0.01 (+16.88%)prev close
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.04 – $0.12
62% from low
Exchange
OTC Link
CS
Price (6 mo)
Loading chart…
Change$-0.05
Valuation
Financials
Loading chart…
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cost of revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross profit | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Gross margin | — | — | — | — | — | — | — | — |
| R&D | $2.6M | $1.2M | $185.3K | $4.9K | $6.2K | $1.4M | $1.7M | $1.7M |
| Operating income | −$4.6M | −$2.7M | −$1.1M | −$325.0K | −$658.0K | −$3.4M | −$3.7M | −$3.4M |
| EBITDA | $0 | −$2.7M | −$1.1M | −$325.0K | −$74 | $378.8K | $318.0K | −$3.4M |
| Net income | −$4.5M | −$2.7M | −$1.1M | −$299.0K | $12.1M | −$3.0M | −$3.3M | −$3.3M |
| Net margin | — | — | — | — | — | — | — | — |
| EPS (diluted) | -0.01 | -0.01 | -0.00 | -0.00 | 0.03 | -0.02 | -0.02 | -0.02 |
Annual figures · source: Financial Modeling Prep
DCF fair valuemodel estimate
Intrinsic value
$0.01
Price
$0.09
Implied downside
-85%
Peer comparison
INHIBITOR THERAPTICS INC
INHIBITOR THERAPTICS INC
Held by traders on TradeandTell
No one on the platform currently holds INTI.
Super investors & insiders
Institutions holding (13F)
No tracked institution reports a position in INTI as of their last filing.
Insider activity (SEC Form 4)
Recent trades on TradeandTell
No one on the platform has traded INTI yet.